ADAM FERGUSON: Open Payments
NPI 1831518075 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 36 payments from 13 companies in 2025. Trend: 2023 $695 · 2024 $871 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $274 |
| Viatris Specialty LLC | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| Novo Nordisk Inc | 3 | $56 |
| Verona Pharma, Inc. | 2 | $44 |
| Electromed, Inc. | 6 | $43 |
| Baxter Healthcare | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: DUPIXENT, YUPELRI, TEZSPIRE, Ohtuvayre, SMARTVEST, Ozempic, Hillrom - Vest System Model 105 Home Care, PURIFIED CORTROPHIN GEL.
Industry payments across LA — which companies pay providers there.
